The Impact of Diet on the Gut-Microbiota-Brain Axis
NMB
An Interventional Study on the Association Between Diet, Cognitive Function, Stress and the Gut Microbiota in Healthy Volunteers.
1 other identifier
interventional
200
1 country
1
Brief Summary
This study aims to investigate the effects of an 8-week dietary intervention on cognitive function, stress, and the gut microbiota in healthy adults with low fibre intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jul 2022
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2022
CompletedFirst Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
July 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
July 16, 2024
July 1, 2024
4 years
June 12, 2023
July 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Trait stress/mood: self-report
self-report questionnaires
Change from baseline at 8 weeks
Trait stress/mood: hypothalamic-pituitary-adrenal axis activity
Cortisol from saliva samples
Change from baseline at 8 weeks
Responses to acute stress: self-report
Self-report questionnaires
Change from baseline at 8 weeks
Responses to acute stress: sympathetic-adrenal-medullary pathway activity
Galvanic skin response taken from the skin on the hand
Change from baseline at 8 weeks
Responses to acute stress: hypothalamic-pituitary-adrenal axis activity
Cortisol from saliva samples
Change from baseline at 8 weeks
Secondary Outcomes (12)
Cognitive performance: working memory
Change from baseline at 8 weeks
Cognitive performance: episodic memory
Change from baseline at 8 weeks
Cognitive performance: decision making
Change from baseline at 8 weeks
Cognitive performance: emotional inhibition
Change from baseline at 8 weeks
Cognitive performance: sustained attention
Change from baseline at 8 weeks
- +7 more secondary outcomes
Study Arms (4)
Control
ACTIVE COMPARATORParticipants will recieve dietary education based on the healthy eating guidleines provided by the Health Service Executive (HSE).
Fermented Foods
EXPERIMENTALFermented foods diet (4-6 portions/day)
High Fibre
EXPERIMENTALHigh fibre diet (24-35 grams/day)
Combined Diet
EXPERIMENTALCombined diet high in fibre and fermented foods (fibre aim 24-35 grams/day, fermented foods aim 4-6 portions/day)
Interventions
Participants will recieve dietary education to include 4 to 6 portions of fermented foods to their normal diet.
Participants will recieve dietary education to increase their fibre intake to 24-35g/day in their normal diet.
Participants will recieve dietary education to increase their fibre intake to 25-30g/day and include 3 to 4 portions of fermented foods to their normal diet.
Participants will recieve dietary education based on the Irish healthy food pyramid.
Eligibility Criteria
You may qualify if:
- Be able to give written informed consent.
- Be between 18 and 50 years of age.
- Have a body mass index (BMI) between 18.5-29.9 Kg/m2.
- Be in generally good health as determined by the investigator.
You may not qualify if:
- Are less than 18 and greater than 50 years of age.
- Have a BMI below 18.5 or above 29.9 Kg/m2.
- Have a significant acute or chronic coexisting illness \[cardiovascular, gastrointestinal (GI) \[to include functional GI disorders, inflammatory bowel disease, coeliac disease, lactose intolerance, food allergies\], immunological, psychiatric \[to include formal or as determined by MINI Psychiatric interview, diagnosis of current major depression, anxiety disorder, bipolar spectrum disorder, schizophrenia, other DSM-IV Axis I disorder\], neurodevelopmental disorders, immunological, metabolic disorders \[to include type I or II diabetes\], or any condition which contraindicates, in the investigators judgement, entry to the study,
- Have a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk, or confound the interpretation of the study results; all psychoactive medications \[to include anxiolytics, antipsychotics, antidepressants, anticonvulsants, centrally acting corticosteroids, and opioid pain relievers), laxatives, enemas, antibiotics, anti-coagulants, over-the counter non-steroidal anti-inflammatories (NSAIDS). Subjects should have a wash-out period of 4 weeks.
- Current prebiotic or probiotic supplement use (a wash-out period of 4 weeks after cessation will allow entry to the study).
- Females who are peri-menopausal, menopausal or post-menopausal.
- Females who are pregnant or planning a pregnancy, or lactating.
- Participants who are not fluent in English.
- Are colour blind.
- Have dyslexia or dyscalculia.
- Are a current habitual daily smoker.
- Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial.
- Subjects receiving treatment involving experimental drugs. If the subject has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.
- Have a malignant disease or any concomitant end-stage organ disease.
- Have completed a study in our laboratory in the past 4 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
APC Microbiome Ireland
Cork, T12YT20, Ireland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Cryan, PhD
APC Microbiome Ireland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2023
First Posted
July 5, 2023
Study Start
July 14, 2022
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
July 16, 2024
Record last verified: 2024-07